(Q51554659)

7 April 2018

title

Hypoxia-Driven Adenosine Accumulation: A Crucial Microenvironmental Factor Promoting Tumor Progression. (English)

1 reference

7 April 2018

1 reference

1 reference

1

Peter Vaupel

1 reference

7 April 2018

author name string

Arnulf Mayer

series ordinal

2

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 January 2016

1 reference

7 April 2018

Advances in Experimental Medicine and Biology

published in

1 reference

7 April 2018

volume

876

1 reference

7 April 2018

page(s)

177-183

1 reference

7 April 2018

Detection and characterization of tumor hypoxia using pO2 histography

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Tumor hypoxia and malignant progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Hypoxia in cancer: significance and impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Hypoxia, lactate accumulation, and acidosis: siblings or accomplices driving tumor progression and resistance to therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Comparison of interstitial fluid and coronary venous adenosine levels in in vivo porcine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Tumor-promoting functions of adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Purines, purinergic receptors, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Accumulation of purine catabolites in solid tumors exposed to therapeutic hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Signalling from adenosine receptors to mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Adenosine receptors and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Immunoregulatory activity of adenosine and its role in human cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Immunity, inflammation and cancer: a leading role for adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Targeting cancer-derived adenosine: new therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Hostile, hypoxia-A2-adenosinergic tumor biology as the next barrier to overcome for tumor immunologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Extracellular adenosine-mediated modulation of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

A glance at adenosine receptors: novel target for antitumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3023-4_22

10.1007/978-1-4939-3023-4_22

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018